PROTECT AGAINST DISTAL EMBOLIZATION
Partnering with Boston Scientific can help mitigate the inherent risks of SVG interventions and protect against distal embolization:
Patients undergoing PCI in SVGs may have increased risk of adverse events due to plaque embolization
Distal embolization during SVG PCI is common, and embolic events cannot be accurately predicted by clinical or angiographic variables1
Mechanical embolic protection devices are used to capture atheroemboli
Use of distal embolic protection devices is an ACC/AHA/SCAI standard of care recommendation2
COMPLICATIONS CAN COST YOU
Embolic complications are frequent and costly in SVG interventions?
42% reduction in incidence of MI
Mean cost of an MI is > $24,000 in the first year
Reduced hospital stay by 0.4 days
Mean cost of a hospital day ($1,500)
Incremental cost-effectiveness ration (ICER) is $3,718 per year of life saved, which is well below the accepted standard of $50,000
LESS RISK, MORE REWARD3
Embolic protection devices are underutilized
Occurrence of distal embolization in SVG cases
Utilization of embolic protection devices, in SVG cases
Retrieval success of particulate debris with use of embolic protection devices
ANGIOJET? Ultra Thrombectomy System
The ANGIOJET Ultra Thrombectomy System is a mechanical thrombectomy device for PCI patients with large thrombus burden. It’s also the ONLY FDA-approved mechanical thrombectomy device for removal of thrombus in coronary arteries. The system is designed to mechanically restore blood flow of patients with thrombosed arteries.
FILTERWIRE EZ? Embolic Protection System
With its advanced technology designed for simplicity and effectiveness, the FILTERWIRE EZ Embolic Protection System is designed to deliver efficient, predictable protection.